Literature DB >> 26045976

Pancreatic cancer stem cells.

Ya-Yun Zhu1, Zhou Yuan1.   

Abstract

Studies are emerging in support of the cancer stem cells (CSCs) theory which considers that a tiny subset of cancer cells is exclusively responsible for the initiation and malignant behavior of a cancer. This cell population, also termed CSCs, possesses the capacity both to self-renew, producing progeny that have the identical tumorigenic potential, and to differentiate into the bulk of cancer cells, helping serve the formation of the tumor entities, which, altogether, build the hierarchically organized structure of a cancer. In this review, we try to articulate the complicated signaling pathways regulating the retention of the characteristics of pancreatic CSCs, and in the wake of which, we seek to offer insights into the CSCs-relevant targeted therapeutics which are, in the meantime, confronted with bigger challenges than ever.

Entities:  

Keywords:  CSC-targeted therapeutic; Pancreatic cancer; cancer stem cells; microRNA; signaling pathway

Year:  2015        PMID: 26045976      PMCID: PMC4449425     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  100 in total

1.  The Notch signaling pathway is related to neurovascular progression of pancreatic cancer.

Authors:  Peter Büchler; Amiq Gazdhar; Mario Schubert; Nathalia Giese; Howard A Reber; Oscar J Hines; Thomas Giese; Güralp O Ceyhan; Michael Müller; Markus W Büchler; Helmut Friess
Journal:  Ann Surg       Date:  2005-12       Impact factor: 12.969

2.  Down-regulation of microRNA-494 via loss of SMAD4 increases FOXM1 and β-catenin signaling in pancreatic ductal adenocarcinoma cells.

Authors:  Lei Li; Zhaoshen Li; Xiangyu Kong; Dacheng Xie; Zhiliang Jia; Weihua Jiang; Jiujie Cui; Yiqi Du; Daoyan Wei; Suyun Huang; Keping Xie
Journal:  Gastroenterology       Date:  2014-05-20       Impact factor: 22.682

3.  Hedgehog signaling is a novel therapeutic target in tamoxifen-resistant breast cancer aberrantly activated by PI3K/AKT pathway.

Authors:  Bhuvaneswari Ramaswamy; Yuanzhi Lu; Kun-Yu Teng; Gerard Nuovo; Xiaobai Li; Charles L Shapiro; Sarmila Majumder
Journal:  Cancer Res       Date:  2012-08-08       Impact factor: 12.701

4.  CD44posCD49fhiCD133/2hi defines xenograft-initiating cells in estrogen receptor-negative breast cancer.

Authors:  Matthew J Meyer; Jodie M Fleming; Amy F Lin; S Amal Hussnain; Erika Ginsburg; Barbara K Vonderhaar
Journal:  Cancer Res       Date:  2010-05-18       Impact factor: 12.701

Review 5.  A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes.

Authors:  O A Kent; J T Mendell
Journal:  Oncogene       Date:  2006-10-09       Impact factor: 9.867

6.  Activation of the Wnt pathway through Wnt2 promotes metastasis in pancreatic cancer.

Authors:  Hua Jiang; Qingqing Li; Chengzhi He; Fengru Li; Haihui Sheng; Xiaoying Shen; Xiaoyan Zhang; Shizhang Zhu; Hui Chen; Ximei Chen; Changqing Yang; Hengjun Gao
Journal:  Am J Cancer Res       Date:  2014-09-06       Impact factor: 6.166

7.  ATDC/TRIM29 phosphorylation by ATM/MAPKAP kinase 2 mediates radioresistance in pancreatic cancer cells.

Authors:  Lidong Wang; Huibin Yang; Phillip L Palmbos; Gina Ney; Taylor Ann Detzler; Dawn Coleman; Jacob Leflein; Mary Davis; Min Zhang; Wenhua Tang; J Kevin Hicks; Corey M Helchowski; Jayendra Prasad; Theodore S Lawrence; Liang Xu; Xiaochun Yu; Christine E Canman; Mats Ljungman; Diane M Simeone
Journal:  Cancer Res       Date:  2014-01-27       Impact factor: 12.701

8.  CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells.

Authors:  Jian Wang; Per Ø Sakariassen; Oleg Tsinkalovsky; Heike Immervoll; Stig Ove Bøe; Agnete Svendsen; Lars Prestegarden; Gro Røsland; Frits Thorsen; Linda Stuhr; Anders Molven; Rolf Bjerkvig; Per Ø Enger
Journal:  Int J Cancer       Date:  2008-02-15       Impact factor: 7.396

9.  KLF8 knockdown suppresses proliferation and invasion in human osteosarcoma cells.

Authors:  Feng Lin; Zan Shen; Li-Na Tang; Shui-Er Zheng; Yuan-Jue Sun; Da-Liu Min; Yang Yao
Journal:  Mol Med Rep       Date:  2014-03-07       Impact factor: 2.952

10.  Human pancreatic cancer contains a side population expressing cancer stem cell-associated and prognostic genes.

Authors:  Anke Van den Broeck; Hugo Vankelecom; Wouter Van Delm; Lies Gremeaux; Jasper Wouters; Joke Allemeersch; Olivier Govaere; Tania Roskams; Baki Topal
Journal:  PLoS One       Date:  2013-09-17       Impact factor: 3.240

View more
  8 in total

1.  Assessment of Three-Drug Combination Pharmacodynamic Interactions in Pancreatic Cancer Cells.

Authors:  Emilie A G Molins; William J Jusko
Journal:  AAPS J       Date:  2018-06-27       Impact factor: 4.009

2.  Ski modulate the characteristics of pancreatic cancer stem cells via regulating sonic hedgehog signaling pathway.

Authors:  Libin Song; Xiangyuan Chen; Song Gao; Chenyue Zhang; Chao Qu; Peng Wang; Luming Liu
Journal:  Tumour Biol       Date:  2016-10-12

Review 3.  Circulating Tumor Cells and Circulating Tumor DNA Provide New Insights into Pancreatic Cancer.

Authors:  Yang Gao; Yayun Zhu; Zhou Yuan
Journal:  Int J Med Sci       Date:  2016-11-04       Impact factor: 3.738

Review 4.  Targeting Cancer Stem Cells and Their Niche: Current Therapeutic Implications and Challenges in Pancreatic Cancer.

Authors:  Jiangang Zhao; Jiahui Li; Hans A Schlößer; Felix Popp; Marie Christine Popp; Hakan Alakus; Karl-Walter Jauch; Christiane J Bruns; Yue Zhao
Journal:  Stem Cells Int       Date:  2017-08-06       Impact factor: 5.443

Review 5.  Cancer stem cells and strategies for targeted drug delivery.

Authors:  Jin Cao; Shubhmita Bhatnagar; Jiawei Wang; Xueyong Qi; Swayam Prabha; Jayanth Panyam
Journal:  Drug Deliv Transl Res       Date:  2020-10-23       Impact factor: 5.671

Review 6.  The Role of miRNAs in the Regulation of Pancreatic Cancer Stem Cells.

Authors:  Sabrina Bimonte; Antonio Barbieri; Maddalena Leongito; Giuseppe Palma; Vitale Del Vecchio; Michela Falco; Raffaele Palaia; Vittorio Albino; Mauro Piccirillo; Alfonso Amore; Antonella Petrillo; Vincenza Granata; Francesco Izzo
Journal:  Stem Cells Int       Date:  2016-02-24       Impact factor: 5.443

7.  The anti-fibrotic effect of GV1001 combined with gemcitabine on treatment of pancreatic ductal adenocarcinoma.

Authors:  Joo Kyung Park; Yejin Kim; Hyemin Kim; Jane Jeon; Tae Wan Kim; Ji-Hong Park; Young-Il Hwnag; Wang Jae Lee; Jae Seung Kang
Journal:  Oncotarget       Date:  2016-11-15

8.  Liver metastasis of pancreatic cancer: the hepatic microenvironment impacts differentiation and self-renewal capacity of pancreatic ductal epithelial cells.

Authors:  Hendrike Knaack; Lennart Lenk; Lisa-Marie Philipp; Lauritz Miarka; Sascha Rahn; Fabrice Viol; Charlotte Hauser; Jan-Hendrik Egberts; Jan-Paul Gundlach; Olga Will; Sanjay Tiwari; Wolfgang Mikulits; Udo Schumacher; Jan G Hengstler; Susanne Sebens
Journal:  Oncotarget       Date:  2018-08-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.